Paul Choi
Stock Analyst at Goldman Sachs
(0)
# 4365
Out of 5,329 analysts
138
Total ratings
49.21%
Success rate
-13.04%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
XENE Xenon Pharmaceutical... | Maintains: Buy | 60 52 | 38.18 | 36.2% | 2 | Apr 17, 2025 | |
VIR Vir Biotechnology | Maintains: Buy | 28 21 | 6.11 | 243.7% | 8 | Apr 17, 2025 | |
URGN UroGen Pharma | Maintains: Neutral | 22 16 | 11.47 | 39.49% | 3 | Apr 17, 2025 | |
RGNX Regenxbio | Maintains: Neutral | 14 12 | 9.87 | 21.58% | 3 | Apr 17, 2025 | |
PHAT Phathom Pharmaceutic... | Maintains: Neutral | 12 10 | 3.35 | 198.51% | 9 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 7 | 1.04 | 573.08% | 5 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 0.98 | 206.12% | 9 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 12 10 | 11.51 | -13.12% | 4 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 12 | 7.24 | 65.75% | 2 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 20 7 | 10.99 | -36.31% | 7 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 225 | 166.64 | 35.02% | 4 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 143 | 106.09 | 34.79% | 1 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 42 | 49.5 | -15.15% | 7 | Dec 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 85 60 | 43.03 | 39.44% | 2 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 19 | 14.79 | 28.47% | 6 | Aug 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 32 | 27.79 | 15.15% | 1 | Jul 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 29 50 | 38.51 | 29.84% | 6 | Jul 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 19 | 4.17 | 355.64% | 3 | Jun 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 16 2 | 0.34 | 488.24% | 7 | Jun 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 29 26 | n/a | n/a | 2 | Apr 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 4 | n/a | n/a | 1 | Oct 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 25 | 1 | 2400% | 3 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 450 100 | n/a | n/a | 3 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 4 | 0.33 | 1112.12% | 4 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 4 | n/a | n/a | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 151 170 | 22.56 | 653.55% | 2 | Oct 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 225 125 | n/a | n/a | 2 | Sep 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 9 8 | 3.08 | 159.74% | 4 | Aug 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 132 | n/a | n/a | 3 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 33 | 29.38 | 12.32% | 1 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 112 | 46.24 | 142.21% | 1 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 30 | n/a | n/a | 1 | Jan 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | n/a | n/a | 1 | Aug 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 48 49 | n/a | n/a | 4 | Jul 15, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 91 103 | n/a | n/a | 2 | Jul 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 135 | 106.71 | 26.51% | 1 | Jun 29, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 240 | n/a | n/a | 2 | Jun 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 5 22 | n/a | n/a | 3 | Apr 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 18 20 | 0.78 | 2464.1% | 2 | Mar 30, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 40 | n/a | n/a | 3 | Oct 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 56 | n/a | n/a | 3 | Aug 6, 2018 |